Skip to main content
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1990 Nov;47(5):795–801.

Deletion mapping of Aland Island eye disease to Xp21 between DXS67 (B24) and Duchenne muscular dystrophy.

D A Pillers 1, J A Towbin 1, J S Chamberlain 1, D Wu 1, J Ranier 1, B R Powell 1, E R McCabe 1
PMCID: PMC1683699  PMID: 2220819

Abstract

Aland Island Eye Disease (AIED) is an X-linked form of ocular hypopigmentation--also known as Forsius-Eriksson, or type 2, ocular albinism--in which affected males demonstrate subnormal visual acuity, protanomalous red-green colorblindness, axial myopia, astigmatism, hypoplasia of the fovea, and hypopigmentation of the fundus. A patient has previously been described who, in addition to AIED, manifested a contiguous gene syndrome which included congenital adrenal hypoplasia (AHC), glycerol kinase deficiency (GKD), and Duchenne muscular dystrophy (DMD). In the present paper report we report the molecular genetic analysis of his deletion. Initially, multiplex polymerase-chain-reaction amplification was used to screen for a DMD-locus deletion which was then further characterized, using DMD cDNA and genomic probes, via Southern blot analysis. The deletion includes the region encompassed by probes C7 (DXS28) and DMD cDNA 8. Probes B24 (DXS67) and DMD cDNA 5b-7 show normal hybridization patterns and appear to flank the deletion, while the DMD cDNA 8 detects a junction fragment. Molecular genetic techniques have mapped the deletion in this patient to the subbands Xp21.3-21.2, between DXS67 and DMD.

Full text

PDF
795

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartley J. A., Patil S., Davenport S., Goldstein D., Pickens J. Duchenne muscular dystrophy, glycerol kinase deficiency, and adrenal insufficiency associated with Xp21 interstitial deletion. J Pediatr. 1986 Feb;108(2):189–192. doi: 10.1016/s0022-3476(86)80980-5. [DOI] [PubMed] [Google Scholar]
  2. Baumbach L. L., Chamberlain J. S., Ward P. A., Farwell N. J., Caskey C. T. Molecular and clinical correlations of deletions leading to Duchenne and Becker muscular dystrophies. Neurology. 1989 Apr;39(4):465–474. doi: 10.1212/wnl.39.4.465. [DOI] [PubMed] [Google Scholar]
  3. Chamberlain J. S., Gibbs R. A., Ranier J. E., Nguyen P. N., Caskey C. T. Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res. 1988 Dec 9;16(23):11141–11156. doi: 10.1093/nar/16.23.11141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chelly J., Marlhens F., Dutrillaux B., Van Ommen G. J., Lambert M., Haioun B., Boissinot G., Fardeau M., Kaplan J. C. Deletion proximal to DXS68 locus (L1 probe site) in a boy with Duchenne muscular dystrophy, glycerol kinase deficiency, and adrenal hypoplasia. Hum Genet. 1988 Mar;78(3):222–227. doi: 10.1007/BF00291665. [DOI] [PubMed] [Google Scholar]
  5. Church G. M., Gilbert W. Genomic sequencing. Proc Natl Acad Sci U S A. 1984 Apr;81(7):1991–1995. doi: 10.1073/pnas.81.7.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Davies K. E., Patterson M. N., Kenwrick S. J., Bell M. V., Sloan H. R., Westman J. A., Elsas L. J., 2nd, Mahan J. Fine mapping of glycerol kinase deficiency and congenital adrenal hypoplasia within Xp21 on the short arm of the human X chromosome. Am J Med Genet. 1988 Mar;29(3):557–564. doi: 10.1002/ajmg.1320290313. [DOI] [PubMed] [Google Scholar]
  7. Dunger D. B., Davies K. E., Pembrey M., Lake B., Pearson P., Williams D., Whitfield A., Dillon M. J. Deletion on the X chromosome detected by direct DNA analysis in one of two unrelated boys with glycerol kinase deficiency, adrenal hypoplasia, and Duchenne muscular dystrophy. Lancet. 1986 Mar 15;1(8481):585–587. doi: 10.1016/s0140-6736(86)92811-4. [DOI] [PubMed] [Google Scholar]
  8. FORSIUS H., ERIKSSON A. W. EIN NEUES AUGENSYNDROM MIT X-CHROMOSOMAL TRANSMISSION. EINE SIPPE MIT FUNDUSALBINISMUS, FOVEAHYPOPLASIE, NYSTAGMUS, MYOPIE, ASTIGMATISMUS UND DYSCHROMATOPSIE. Klin Monbl Augenheilkd. 1964 Apr;144:447–457. [PubMed] [Google Scholar]
  9. Feinberg A. P., Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 1983 Jul 1;132(1):6–13. doi: 10.1016/0003-2697(83)90418-9. [DOI] [PubMed] [Google Scholar]
  10. Francke U., Harper J. F., Darras B. T., Cowan J. M., McCabe E. R., Kohlschütter A., Seltzer W. K., Saito F., Goto J., Harpey J. P. Congenital adrenal hypoplasia, myopathy, and glycerol kinase deficiency: molecular genetic evidence for deletions. Am J Hum Genet. 1987 Mar;40(3):212–227. [PMC free article] [PubMed] [Google Scholar]
  11. Guggenheim M. A., McCabe E. R., Roig M., Goodman S. I., Lum G. M., Bullen W. W., Ringel S. P. Glycerol kinase deficiency with neuromuscular, skeletal, and adrenal abnormalities. Ann Neurol. 1980 May;7(5):441–449. doi: 10.1002/ana.410070509. [DOI] [PubMed] [Google Scholar]
  12. Hammond J., Howard N. J., Brookwell R., Purvis-Smith S., Wilcken B., Hoogenraad N. Proposed assignment of loci for X-linked adrenal hypoplasia and glycerol kinase genes. Lancet. 1985 Jan 5;1(8419):54–54. doi: 10.1016/s0140-6736(85)91009-8. [DOI] [PubMed] [Google Scholar]
  13. Kan Y. W., Dozy A. M., Trecartin R., Todd D. Identification of a nondeletion defect in alpha-thalassemia. N Engl J Med. 1977 Nov 17;297(20):1081–1084. doi: 10.1056/NEJM197711172972002. [DOI] [PubMed] [Google Scholar]
  14. Koenig M., Hoffman E. P., Bertelson C. J., Monaco A. P., Feener C., Kunkel L. M. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell. 1987 Jul 31;50(3):509–517. doi: 10.1016/0092-8674(87)90504-6. [DOI] [PubMed] [Google Scholar]
  15. Marlhens F., Chelly J., Kaplan J. C., Lefrancois D., Harpey J. P., Dutrillaux B. Familial deletion of Xp21.2 with glycerol kinase deficiency and congenital adrenal hypoplasia. Hum Genet. 1987 Dec;77(4):379–383. doi: 10.1007/BF00291430. [DOI] [PubMed] [Google Scholar]
  16. Matsumoto T., Kondoh T., Yoshimoto M., Fujieda K., Matsuura N., Matsuda I., Miike T., Yano K., Okuno A., Aoki Y. Complex glycerol kinase deficiency: molecular-genetic, cytogenetic, and clinical studies of five Japanese patients. Am J Med Genet. 1988 Nov;31(3):603–616. doi: 10.1002/ajmg.1320310315. [DOI] [PubMed] [Google Scholar]
  17. McCabe E. R., Fennessey P. V., Guggenheim M. A., Miles B. S., Bullen W. W., Sceats D. J., Goodman S. I. Human glycerol kinase deficiency with hyperglycerolemia and glyceroluria. Biochem Biophys Res Commun. 1977 Oct 24;78(4):1327–1333. doi: 10.1016/0006-291x(77)91437-1. [DOI] [PubMed] [Google Scholar]
  18. McCabe E. R., Towbin J., Chamberlain J., Baumbach L., Witkowski J., van Ommen G. J., Koenig M., Kunkel L. M., Seltzer W. K. Complementary DNA probes for the Duchenne muscular dystrophy locus demonstrate a previously undetectable deletion in a patient with dystrophic myopathy, glycerol kinase deficiency, and congenital adrenal hypoplasia. J Clin Invest. 1989 Jan;83(1):95–99. doi: 10.1172/JCI113890. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Pearce W. G., Johnson G. J., Sanger R. Ocular albinism and Xg. Lancet. 1971 May 22;1(7708):1072–1072. doi: 10.1016/s0140-6736(71)91636-9. [DOI] [PubMed] [Google Scholar]
  20. Pillers D. A., Weleber R. G., Powell B. R., Hanna C. E., Magenis R. E., Buist N. R. Aland Island eye disease (Forsius-Eriksson ocular albinism) and an Xp21 deletion in a patient with Duchenne muscular dystrophy, glycerol kinase deficiency, and congenital adrenal hypoplasia. Am J Med Genet. 1990 May;36(1):23–28. doi: 10.1002/ajmg.1320360106. [DOI] [PubMed] [Google Scholar]
  21. Poncz M., Solowiejczyk D., Harpel B., Mory Y., Schwartz E., Surrey S. Construction of human gene libraries from small amounts of peripheral blood: analysis of beta-like globin genes. Hemoglobin. 1982;6(1):27–36. doi: 10.3109/03630268208996930. [DOI] [PubMed] [Google Scholar]
  22. Reed K. C., Mann D. A. Rapid transfer of DNA from agarose gels to nylon membranes. Nucleic Acids Res. 1985 Oct 25;13(20):7207–7221. doi: 10.1093/nar/13.20.7207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Schnur R. E., Trask B. J., van den Engh G., Punnett H. H., Kistenmacher M., Tomeo M. A., Naids R. E., Nussbaum R. L. An Xp22 microdeletion associated with ocular albinism and ichthyosis: approximation of breakpoints and estimation of deletion size by using cloned DNA probes and flow cytometry. Am J Hum Genet. 1989 Nov;45(5):706–720. [PMC free article] [PubMed] [Google Scholar]
  24. Southern E. M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 1975 Nov 5;98(3):503–517. doi: 10.1016/s0022-2836(75)80083-0. [DOI] [PubMed] [Google Scholar]
  25. Towbin J. A., Wu D. R., Chamberlain J., Larsen P. D., Seltzer W. K., McCabe E. R. Characterization of patients with glycerol kinase deficiency utilizing cDNA probes for the Duchenne muscular dystrophy locus. Hum Genet. 1989 Sep;83(2):122–126. doi: 10.1007/BF00286703. [DOI] [PubMed] [Google Scholar]
  26. Weleber R. G., Pillers D. A., Powell B. R., Hanna C. E., Magenis R. E., Buist N. R. Aland Island eye disease (Forsius-Eriksson syndrome) associated with contiguous deletion syndrome at Xp21. Similarity to incomplete congenital stationary night blindness. Arch Ophthalmol. 1989 Aug;107(8):1170–1179. doi: 10.1001/archopht.1989.01070020236032. [DOI] [PubMed] [Google Scholar]
  27. Wieringa B., Hustinx T., Scheres J., Renier W., ter Haar B. Complex glycerol kinase deficiency syndrome explained as X-chromosomal deletion. Clin Genet. 1985 May;27(5):522–523. doi: 10.1111/j.1399-0004.1985.tb00244.x. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES